The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Circadian Melatonin Rhythm and Excessive Daytime Sleepiness in Parkinson Disease
Open accessAbstract
IMPORTANCE: Diurnal fluctuations of motor and nonmotor symptoms and a high prevalence of sleep-wake disturbances in Parkinson disease (PD) suggest a role of the circadian system in the modulation of these symptoms. However, surprisingly little is known regarding circadian function in PD and whether circadian dysfunction is involved in the development of sleep-wake disturbances in PD. OBJECTIVE: To determine the relationship between the timing and amplitude of the 24-hour melatonin rhythm, a marker of endogenous circadian rhythmicity, with self-reported sleep quality, the severity of daytime sleepiness, and disease metrics. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional study from January 1, 2009, through December 31, 2012, of 20 patients with PD receiving stable dopaminergic therapy and 15 age-matched control participants. Both groups underwent blood sampling for the measurement of serum melatonin levels at 30-minute intervals for 24 hours under modified constant routine conditions at the Parkinson's Disease and Movement Disorders Center of Northwestern University. INTERVENTIONS: Twenty-four hour monitoring of serum melatonin secretion. MAIN OUTCOMES AND MEASURES: Clinical and demographic data, self-reported measures of sleep quality (Pittsburgh Sleep Quality Index) and daytime sleepiness (Epworth Sleepiness Scale), and circadian markers of the melatonin rhythm, including the amplitude, area under the curve (AUC), and phase of the 24-hour rhythm. RESULTS: Patients with PD had blunted circadian rhythms of melatonin secretion compared with controls; the amplitude of the melatonin rhythm and the 24-hour AUC for circulating melatonin levels were significantly lower in PD patients (P < .001). Markers of the circadian phase were not significantly different between the 2 groups. Compared with PD patients without excessive daytime sleepiness, patients with excessive daytime sleepiness (Epworth Sleepiness Scale score ≥10) had a significantly lower amplitude of the melatonin rhythm and 24-hour melatonin AUC (P = .001). Disease duration, Unified Parkinson's Disease Rating Scale scores, levodopa equivalent dose, and global Pittsburgh Sleep Quality Index score in the PD group were not significantly related to measures of the melatonin circadian rhythm. CONCLUSIONS AND RELEVANCE: Circadian dysfunction may underlie excessive sleepiness in PD. The nature of this association needs to be explored further in longitudinal studies. Approaches aimed to strengthen circadian function, such as timed exposure to bright light and exercise, might serve as complementary therapies for the nonmotor manifestations of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Compared with healthy aged people, individuals with AD or PD show considerably lower melatonin rhythm amplitudes and excessive sleepiness, as well as other sleep–wake cycle disturbances, such as later sleep onsets254–258.”
From Rhythms of life: circadian disruption and brain disorders across the lifespan (2019) · cites this paper as [258]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Robust Locally Weighted Regression and Smoothing Scatterplots
Cleveland, W. S. (1979) · Journal of the American Statistical Association · doi:10.1080/01621459.1979.10481038 · Cited by 11,594
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients
Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996) · Journal of Personality Assessment · doi:10.1207/s15327752jpa6703_13 · Cited by 5,965
Using the Berlin Questionnaire To Identify Patients at Risk for the Sleep Apnea Syndrome
Netzer, N. C., Stoohs, R. A., Netzer, C. M., Clark, K., & Strohl, K. P. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00002 · Cited by 2,973
Recent developments in Parkinson's disease
Fahn, S., Elton, R., MARSDEN, C. D., Calne, D. B., & Goldstein, M. (1986) · Raven Press eBooks · Cited by 2,306
Transplanted Suprachiasmatic Nucleus Determines Circadian Period
Ralph, M. R., Foster, R. G., Davis, F. C., & Menaker, M. (1990) · Science · doi:10.1126/science.2305266 · Cited by 1,853
Cited by
Sorted by citations
Mechanisms linking circadian clocks, sleep, and neurodegeneration
Musiek, E. S., & Holtzman, D. M. (2016) · Science · doi:10.1126/science.aah4968 · Cited by 878
Rhythms of life: circadian disruption and brain disorders across the lifespan
Logan, R. W., & McClung, C. A. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0088-y · Cited by 713
Association between circadian rhythms and neurodegenerative diseases
Leng, Y., Musiek, E. S., Hu, K., Cappuccio, F. P., & Yaffe, K. S. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30461-7 · Cited by 677
Melatonin as a Hormone: New Physiological and Clinical Insights
Cipolla‐Neto, J., & do Amaral, F. G. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00084 · Cited by 685
The aging clock: circadian rhythms and later life
Hood, S., & Amir, S. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90328 · Cited by 645
Circadian disruption and human health
Fishbein, A. B., Knutson, K. L., & Zee, P. C. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148286 · Cited by 468
Self-citationA review of sleep disorders and melatonin
Xie, Z., Chen, F., Li, W. A., Geng, X., Li, C., Meng, X., Feng, Y., Liu, W., & Yu, F. (2017) · Neurological Research · doi:10.1080/01616412.2017.1315864 · Cited by 409
'The clocks that time us'—circadian rhythms in neurodegenerative disorders
Videnović, A., Lázár, A. S., Barker, R. A., & Overeem, S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.206 · Cited by 381
Circadian Rhythms, Sleep, and Disorders of Aging
Mattis, J., & Sehgal, A. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.02.003 · Cited by 369
Chahine, L., Amara, A., & Videnovic, A. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.08.001 · Cited by 306
Sleep Disturbance, Cognitive Decline, and Dementia: A Review
Wu, M. N., Rosenberg, P. B., Spira, A. P., & Wennberg, A. M. V. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1604351 · Cited by 325
Stefani, A., & Högl, B. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0448-y · Cited by 276
Circadian rhythms in neurodegenerative disorders
Nassan, M. M., & Videnović, A. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00577-7 · Cited by 266
Videnovic, A., Klerman, E. B., Wang, W., Marconi, A., Kuhta, T., & Zee, P. C. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.5192 · Cited by 255
Self-citationThe neuroprotective role of melatonin in neurological disorders
Alghamdi, B. S. A. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24220 · Cited by 234
Melatonin: Clinical Perspectives in Neurodegeneration
Cardinali, D. P. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00480 · Cited by 210
Si, X., Guo, T., Wang, Z., Fang, Y., Gu, L., Cao, L., Yang, W., Gao, T., Song, Z., Tian, J., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00316-9 · Cited by 204
Melatonin receptors: distribution in mammalian brain and their respective putative functions
Ng, K. Y., Leong, M. K., Liang, H., & Paxinos, G. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1439-6 · Cited by 183
Circadian disruption and sleep disorders in neurodegeneration
Shen, Y., Lv, Q.-K., Xie, W.-Y., Gong, S.-Y., Zhuang, S., Liu, J.-Y., Mao, C.-J., & Liu, C.-F. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00340-6 · Cited by 171
Universal method for robust detection of circadian state from gene expression
Braun, R., Kath, W. L., Iwanaszko, M., Kula-Eversole, E., Abbott, S. M., Reid, K. J., Zee, P. C., & Allada, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800314115 · Cited by 175
Self-citationCircadian disruption and human health: A bidirectional relationship
Abbott, S. M., Malkani, R. G., & Zee, P. C. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14298 · Cited by 161
Self-citationNeurodegeneration and the Circadian Clock
Hood, S., & Amir, S. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00170 · Cited by 152
Sleep in Parkinson's disease: A systematic review and meta-analysis of polysomnographic findings
Zhang, Y., Ren, R., Sanford, L. D., Yang, L., Zhou, J., Tan, L., Li, T., Zhang, J., Wing, Y. K., Shi, J., et al. (2020) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101281 · Cited by 151
Assessment of Circadian Rhythms
Reid, K. J. (2019) · Neurologic Clinics · doi:10.1016/j.ncl.2019.05.001 · Cited by 152
Self-citationLeng, Y., Blackwell, T., Cawthon, P. M., Ancoli‐Israel, S., Stone, K. L., & Yaffe, K. S. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1623 · Cited by 140
Neurodegenerative Disorders and Sleep
Malhotra, R. K. (2018) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2017.09.006 · Cited by 127
Chronic sleep disturbance and neural injury: links to neurodegenerative disease
Videnović, A., & Abbott, S. M. (2016) · Nature and Science of Sleep · doi:10.2147/nss.s78947 · Cited by 133
Circadian clock disruption in neurodegenerative diseases: cause and effect?
Musiek, E. S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00029 · Cited by 125
Plasma melatonin is reduced in Huntington's disease
Kalliolia, E., Silajdžić, E., Nambron, R., Hill, N. R., Doshi, A., Frost, C. D., Watt, H., Hindmarsh, P. C., Björkqvist, M., & Warner, T. T. (2014) · Movement Disorders · doi:10.1002/mds.26003 · Cited by 118
Steele, T. A., Louis, E. K. S., Videnović, A., & Auger, R. R. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01031-8 · Cited by 128
Circadian system — A novel diagnostic and therapeutic target in Parkinson's disease?
Videnović, A., & Willis, G. L. (2016) · Movement Disorders · doi:10.1002/mds.26509 · Cited by 115
Retinal Ganglion Cells and Circadian Rhythms in Alzheimer’s Disease, Parkinson’s Disease, and Beyond
Morgia, C. L., Ross‐Cisneros, F. N., Sadun, A. A., & Carelli, V. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00162 · Cited by 116
Disrupted sleep and circadian rhythms in schizophrenia and their interaction with dopamine signaling
Ashton, A., & Jagannath, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00636 · Cited by 106
Sleep and circadian rhythms in Parkinson’s disease and preclinical models
Hunt, J., Coulson, E. J., Rajnarayanan, R. V., Oster, H., Videnović, A., & Rawashdeh, O. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00504-w · Cited by 118
Sleep Issues in Parkinson's Disease and Their Management
Zuzuárregui, J. R. P., & During, E. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00938-y · Cited by 117
Circadian Rhythm Sleep–Wake Disorders in Older Adults
Kim, J. H., Elkhadem, A. R., & Duffy, J. F. (2022) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2022.02.003 · Cited by 111
Workshop report. Circadian rhythm sleep–wake disorders: gaps and opportunities
Duffy, J. F., Abbott, S. M., Burgess, H. J., Crowley, S. J., Emens, J. S., Epstein, L. J., Gamble, K. L., Hasler, B. P., Kristo, D. A., Malkani, R. G., et al. (2021) · SLEEP · doi:10.1093/sleep/zsaa281 · Cited by 100
Self-citationSleep in Neurodegenerative Diseases
Iranzo, Á. (2016) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2015.10.011 · Cited by 100
An overview of sleep and circadian dysfunction in Parkinson's disease
Mantovani, S., Smith, S. S., Gordon, R., & O’Sullivan, J. D. (2018) · Journal of Sleep Research · doi:10.1111/jsr.12673 · Cited by 105
Clinical trials in REM sleep behavioural disorder: challenges and opportunities
Videnović, A., Ju, Y. S., Arnulf, I., Cock, V. C. D., Högl, B., Kunz, D., Provini, F., Ratti, P., Schiess, M. C., Schenck, C. H., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-322875 · Cited by 97
Keeping an eye on circadian time in clinical research and medicine
Klerman, E. B., Brager, A. J., Carskadon, M. A., Depner, C. M., Foster, F., Goel, N., Harrington, M. E., Holloway, P. M., Knauert, M. P., LeBourgeois, M. K., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1131 · Cited by 99
Self-citationSleep fragmentation and Parkinson's disease pathology in older adults without Parkinson's disease
Sohail, S., Yu, L., Schneider, J. A., Bennett, D. A., Buchman, A. S., & Lim, A. S. P. (2017) · Movement Disorders · doi:10.1002/mds.27200 · Cited by 97
Circadian Rhythm Sleep-Wake Disorders in Older Adults
Kim, J. H., & Duffy, J. F. (2017) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2017.09.004 · Cited by 96
Sekiguchi, H., Iritani, S., & Fujita, K. (2017) · Psychogeriatrics · doi:10.1111/psyg.12233 · Cited by 91
Cristini, J., Weiss, M., Heras, B. D. L., Medina‐Rincón, A., Dagher, A., Postuma, R. B., Huber, R., Doyon, J., Rosa‐Neto, P., Carrier, J., et al. (2020) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101384 · Cited by 93
Palagini, L., Manni, R., Aguglia, E., Amore, M., Brugnoli, R., Bioulac, S., Bourgin, P., Micoulaud‐Franchi, J., Girardi, P., Grassi, L. G., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.688890 · Cited by 96
Defining circadian disruption in neurodegenerative disorders
Colwell, C. S. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148288 · Cited by 90
Melanopsin-mediated pupil function is impaired in Parkinson’s disease
Joyce, D. S., Feigl, B., Kerr, G., Roeder, L., & Zele, A. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-26078-0 · Cited by 91
Multifactorial sleep disturbance in Parkinson's disease
Albers, J. A., Chand, P., & Anch, A. M. (2017) · Sleep Medicine · doi:10.1016/j.sleep.2017.03.026 · Cited by 89
Nigrostriatal Dopamine Acting on Globus Pallidus Regulates Sleep
Qiu, M., Yao, Q.-L., Vetrivelan, R., Chen, M. C., & Lu, J. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu241 · Cited by 89
A New Perspective for Parkinson’s Disease: Circadian Rhythm
Li, S., Wang, Y., Wang, F., Hu, L., & Liu, C. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0089-7 · Cited by 86
Neuroendocrine abnormalities in Parkinson's disease
Pablo‐Fernández, E. D., Breen, D. P., Bouloux, P. M., Barker, R. A., Foltynie, T., & Warner, T. T. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314601 · Cited by 89
Pablo‐Fernández, E. D., Courtney, R. J., Warner, T. T., & Holton, J. L. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0640 · Cited by 88
Julienne, H., Buhl, E., Leslie, D. S., & Hodge, J. J. L. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.014 · Cited by 90
Mack, J. M., Schamne, M. G., Sampaio, T. B., Pértile, R. A. N., Fernandes, P. A. C. M., Markus, R. P., & Prediger, R. D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3472032 · Cited by 81
Capriotti, T., & Terzakis, K. (2016) · Home Healthcare Now · doi:10.1097/nhh.0000000000000398 · Cited by 81
Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease
Breen, D. P., Nombela, C., Vuono, R., Jones, P. S., Fisher, K., Burn, D. J., Brooks, D. J., Reddy, A. B., Rowe, J. B., & Barker, R. A. (2016) · Movement Disorders · doi:10.1002/mds.26592 · Cited by 79
Daytime Sleepiness in Parkinson’s Disease: A Reappraisal
Cock, V. C. D., Bayard, S., Jaussent, I., Charif, M., Grini-Mazouzi, M., Langenier, M. C., Yu, H., Lopez, R., Gény, C., Carlander, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107278 · Cited by 75
The Spectrum of Sleep Disorders in Parkinson Disease
Lajoie, A. C., Lafontaine, A., & Kamińska, M. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.09.099 · Cited by 81
Consequences of Circadian Disruption on Neurologic Health
Videnović, A., & Zee, P. C. (2015) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2015.08.004 · Cited by 75
Self-citationSleep as a Therapeutic Target in the Aging Brain
Bah, T. M., Goodman, J. R., & Iliff, J. J. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00769-6 · Cited by 76
Management of Sleep Disturbances in Parkinson’s Disease
Schütz, L., Sixel‐Döring, F., & Hermann, W. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-212749 · Cited by 83
Ahn, J. H., Kim, M., Park, S., Jang, W., Park, J., Oh, E., Cho, J. W., Kim, J. S., & Youn, J. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.03.029 · Cited by 73
Circadian and Sleep Dysfunctions in Neurodegenerative Disorders—An Update
Fifel, K., & Videnović, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.627330 · Cited by 71
Circadian Rhythms and Astrocytes: The Good, the Bad, and the Ugly
Hastings, M. H., Brancaccio, M., Gonzalez-Aponte, M. F., & Herzog, E. D. (2023) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-100322-112249 · Cited by 72
Influence of Circadian Rhythm in the Eye: Significance of Melatonin in Glaucoma
Martínez‐Águila, A., Martín‐Gil, A., Carpena‐Torres, C., Pastrana, C., & Carracedo, G. (2021) · Biomolecules · doi:10.3390/biom11030340 · Cited by 72
Xi, Y., Liu, M., Xu, S.-Z., Hong, H., Chen, M., Tian, L., Xie, J., Deng, P., Zhou, C., Zhang, L., et al. (2019) · Journal of Pineal Research · doi:10.1111/jpi.12596 · Cited by 66
Cheng, W., Ho, J. Y. S., & Chang, R. C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101620 · Cited by 71
Imaging the Limbic System in Parkinson’s Disease—A Review of Limbic Pathology and Clinical Symptoms
Banwinkler, M., Theis, H., Prange, S., & van Eimeren, T. (2022) · Brain Sciences · doi:10.3390/brainsci12091248 · Cited by 70
Roles of clock genes in the pathogenesis of Parkinson's disease
Shkodina, A. D., Tan, S. C., Hasan, M. M., Abdelgawad, M., Chopra, H., Bilal, M., Boiko, D. I., Tarianyk, K. А., & Alexiou, A. T. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101554 · Cited by 67
Reduced coupling of global brain function and cerebrospinal fluid dynamics in Parkinson’s disease
Wang, Z., Song, Z., Zhou, C., Fang, Y., Gu, L., Yang, W., Gao, T., Si, X., Liu, Y., Chen, Y., et al. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231164337 · Cited by 70
Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease
Perez‐Lloret, S., & Cardinali, D. P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.650597 · Cited by 66
Song, Y., Liu, Y., Yuan, Y., Jia, X., Zhang, W., Wang, G., Jia, Y., Wang, X., Liu, L., Li, W., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103490 · Cited by 64
Circadian dysregulation in Parkinson's disease
Videnovic, A., & Golombek, D. (2017) · Neurobiology of Sleep and Circadian Rhythms · doi:10.1016/j.nbscr.2016.11.001 · Cited by 63
Excessive Daytime Sleepiness Predicts Neurodegeneration in Idiopathic REM Sleep Behavior Disorder
Zhou, J., Zhang, J., Lam, S. P., Chan, J. W. Y., Mok, V., Chan, A. Y. Y., Li, S. X., Liu, Y., Tang, X., Yung, W., et al. (2017) · SLEEP · doi:10.1093/sleep/zsx041 · Cited by 63
Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease
Yousaf, T., Pagano, G., Niccolini, F., & Politis, M. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.02.032 · Cited by 63
Baschieri, F., & Cortelli, P. (2019) · Autonomic Neuroscience · doi:10.1016/j.autneu.2019.01.009 · Cited by 62
A lterations of the circadian system in P arkinson's disease patients
Fifel, K. (2016) · Movement Disorders · doi:10.1002/mds.26865 · Cited by 63
Sleep Dysfunction in Parkinson's Disease
Falup‐Pecurariu, C., & Diaconu, Ș. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.033 · Cited by 61
Ma, H., Yan, J., Sun, W., Jiang, M., & Zhang, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.784314 · Cited by 62
Circadian disruption and cancer- and treatment-related symptoms
Amidi, A., & Wu, L. M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1009064 · Cited by 66
Phillipson, O. T. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.09.006 · Cited by 60
Excessive Daytime Sleepiness in Parkinson's Disease
Shen, Y., Huang, J.-Y., Li, J., & Liu, C. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.229889 · Cited by 59
Weissová, K., Škrabalová, J., Skálová, K., Červená, K., Bendová, Z., Miletínová, E., Kopřivová, J., Šonka, K., Dudysová, D., Bartoš, A., et al. (2018) · Sleep Medicine · doi:10.1016/j.sleep.2018.07.019 · Cited by 58
Gilat, M., Marshall, N. S., Testelmans, D., Buyse, B., & Lewis, S. J. G. (2021) · Journal of Neurology · doi:10.1007/s00415-020-10353-0 · Cited by 58
Chronotherapies for Parkinson’s disease
Fifel, K., & Videnović, A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.01.002 · Cited by 58
Sleep disturbance in movement disorders: insights, treatments and challenges
Bailey, G. A., Hubbard, E., Fasano, A. A., Tijssen, M. A. J., Lynch, T., Anderson, K. N., & Peall, K. J. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325546 · Cited by 58
Excessive daytime sleepiness, objective napping and 11-year risk of Parkinson’s disease in older men
Leng, Y., Goldman, S. M., Cawthon, P. M., Stone, K. L., Ancoli‐Israel, S., & Yaffe, K. S. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy098 · Cited by 55
Fung, C. H., Vitiello, M. V., Alessi, C., & Kuchel, G. A. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14493 · Cited by 52
Swanson, G. R., Gorenz, A., Shaikh, M. W., Desai, V., Forsyth, C. B., Fogg, L., Burgess, H. J., & Keshavarzian, A. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00002.2015 · Cited by 52
Melatonin Receptor as a Drug Target for Neuroprotection
Wongprayoon, P., & Govitrapong, P. (2020) · Current Molecular Pharmacology · doi:10.2174/1874467213666200421160835 · Cited by 51
Sleep Pharmacogenetics: Personalized Sleep-Wake Therapy
Holst, S. C., Valomon, A., & Landolt, H. (2015) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103801 · Cited by 48
Insomnia in neurological disorders: Prevalence, mechanisms, impact and treatment approaches.
de Bergeyck, R., & Geoffroy, P. (2023) · Revue neurologique (Paris) · doi:10.1016/j.neurol.2023.08.008 · Cited by 44
Sleep disorders and Parkinson disease; lessons from genetics
Gan‐Or, Z., Alcalay, R. N., Rouleau, G. A., & Postuma, R. B. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2018.01.006 · Cited by 47
Hadi, F., Agah, E., Tavanbakhsh, S., Mirsepassi, Z., Mousavi, S. V., Talachi, N., Tafakhori, A., & Aghamollaii, V. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06188-4 · Cited by 46
Association between Sleep, Alzheimer’s, and Parkinson’s Disease
Matsumoto, S., & Tsunematsu, T. (2021) · Biology · doi:10.3390/biology10111127 · Cited by 45
Circadian Rhythm Abnormalities in Parkinson’s Disease from Humans to Flies and Back
Lazzari, F. D., Bisaglia, M., Zordan, M. A., & Sandrelli, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123911 · Cited by 46
Gu, L., Dai, S., Guo, T., Si, X., Lv, D., Wang, Z., Lu, J., Fang, Y., Guan, X., Zhou, C., et al. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.105254 · Cited by 42
Association between circadian disruption and diseases: A narrative review
Hou, Y., Liu, L.-M., Chen, X., Li, Q., & Li, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118512 · Cited by 48
Treatment of isolated REM sleep behavior disorder using melatonin as a chronobiotic
Kunz, D., Stotz, S., & Bes, F. (2021) · Journal of Pineal Research · doi:10.1111/jpi.12759 · Cited by 42
Metadata
- Authors
- Videnovic, A., Noble, C., Reid, K. J., Peng, J., Turek, F. W., Marconi, A., Rademaker, A. W., Simuni, T., Zadikoff, C., & Zee, P. C.
- Affiliations
- Neurological Clinical Research Institute, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts2Department of Neurology, Northwestern University, Chicago, Illinois
- Northwestern University (US)
- ORCID
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2014-04-01
- Volume
- 71
- Issue
- 4
- Pages
- 463
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC4078989
- OpenAlex
- W1980509662
- Cited by
- 390
- References
- 51
- Citations by year
- 2026: 22 · 2025: 46 · 2024: 33 · 2023: 29 · 2022: 41 · 2021: 43 · 2020: 31 · 2019: 28 · 2018: 27 · 2017: 34 · 2016: 33 · 2015: 11 · 2014: 12
- FWCI
- 14.63
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR000150)
- National Institute on Alcohol Abuse and Alcoholism (R01AA020216)
- National Institute on Aging (P01-AG11412., P01AG011412)
- National Heart, Lung, and Blood Institute (R01HL090873, R01HL105549, UM1HL112856)
- National Institute of Neurological Disorders and Stroke (K23NS072283, U10NS053377, U01NS050324, U01NS050095)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- excessive daytime sleepiness, melatonin rhythm, circadian dysfunction, sleep-wake disturbances, sleep quality, melatonin secretion, non-motor symptoms, circadian phase, dopaminergic therapy, phototherapy, exercise therapy, melatonin supplementation, melatonin receptor agonists
- MeSH terms
- Aged, Circadian Rhythm, Cross-Sectional Studies, Female, Humans, Disorders of Excessive Somnolence, Male, Melatonin, Middle Aged, Parkinson Disease, Registries, Severity of Illness Index, Cohort Studies, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review